Open Access

[Corrigendum] STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway

  • Authors:
    • Wenpeng Jiang
    • Shiting Huang
    • Liang Song
    • Zhou Wang
  • View Affiliations

  • Published online on: November 13, 2020     https://doi.org/10.3892/or.2020.7855
  • Pages: 401-402
  • Copyright : © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

January-2021
Volume 45 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiang W, Huang S, Song L and Wang Z: [Corrigendum] STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway. Oncol Rep 45: 401-402, 2021.
APA
Jiang, W., Huang, S., Song, L., & Wang, Z. (2021). [Corrigendum] STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway. Oncology Reports, 45, 401-402. https://doi.org/10.3892/or.2020.7855
MLA
Jiang, W., Huang, S., Song, L., Wang, Z."[Corrigendum] STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway". Oncology Reports 45.1 (2021): 401-402.
Chicago
Jiang, W., Huang, S., Song, L., Wang, Z."[Corrigendum] STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway". Oncology Reports 45, no. 1 (2021): 401-402. https://doi.org/10.3892/or.2020.7855